Skip to main content
Premium Trial:

Request an Annual Quote

Waters Shares Sink 11.7 Percent After Company Cuts Revenue Projections, Its Second Cut in Seven Months

NEW YORK, Oct. 14 (GenomeWeb News) - Shares of Waters' stock were down 11.67 percent, or $4.83, at $36.55 in mid-afternoon trading after the company this morning reported that "slower thanexpected" sales growth has forced it to lower its third-quarter sales and earnings-per-share expectations.


In its second-quarter conference call July 26, Waters said it anticipated sales to grow 8 percent in the third quarter year over year. The company now expects growth to be around 3 percent year over year.


This is the secomd time in seven months that Waters was forced to lower its projections. In March, the company said it would revise its projected first-quarter earnings from $.44 to between $.34 and $.37 per diluted share. At that time, the firm also cited "weaker thanexpected sales growth" as cause for decreasing its sales growth projections to 3 to 4 percent from 13 to 14 percent.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.